Transplant with MZ genotype liver: what is the clinical pulmonary picture after 30 years? a case report and review of the literature

J Med Case Rep. 2023 Nov 2;17(1):475. doi: 10.1186/s13256-023-04183-7.

Abstract

Background: Alpha-1 antitrypsin, also known as alpha1 proteinase inhibitor, is a protein 90% synthesized by hepatocytes. Alpha-1 antitrypsin deficiency should be suspected if patients have unexplained emphysema or liver disease in the absence of others recognized causes. The diagnosis is based on tests that measure the amount of the enzyme in the blood and confirm by molecular analysis.

Case presentation: We present the case of a man of Caucasian ethnicity, who started experiencing difficulty in breathing 20 years after liver transplantation. After about 30 years since transplantation, an intermediate alpha-1 antitrypsin deficiency is diagnosed with evidence of air trapping, pulmonary emphysema and bronchiectasis.

Conclusion: The presence of a Z-variant synthesized from the donor liver may have contribute to the onset of respiratory disease.

Keywords: Alpha 1 antitrypsin; Liver transplant; Lung disease.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Genotype
  • Humans
  • Liver Transplantation* / adverse effects
  • Living Donors
  • Pulmonary Emphysema* / etiology
  • alpha 1-Antitrypsin Deficiency* / complications
  • alpha 1-Antitrypsin Deficiency* / diagnosis
  • alpha 1-Antitrypsin Deficiency* / genetics